CLINICAL_TRIALS
trial_result
· 2015-10-19
Clinical Trial Update: Phase II Exploratory Clinical Study of KUX-1151 [Phase 2]
Summary
A Phase II exploratory study of KUX-1151 by Kissei Pharmaceutical for hyperuricemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED